GENE ONLINE|News &
Opinion
Blog

CRO
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Parexel and Japanese Foundation for Cancer Research Collaborate to Boost Oncology Clinical Trials in Japan
2024-01-18
APAC-Focused Novotech Buys US CRO and Expands Global Footprint
2022-05-06
APAC CRO Novotech Mulls IPO after $255 Million Round
2022-01-20
GeneOnline’s Top 10 M&As of 2021
2022-01-11
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
Thermo Fisher Bolsters Clinical Research Services with $17.4 Billion Acquisition of PPD
2021-12-10
Are Decentralized Clinical Trials Taking Root in Japan?
2021-10-29
Booming Bioanalytical CRO Sets Sights on Australian Market with 360biolabs Acquisition
2021-08-17
EQT Private Equity and Goldman Sachs Spend $8.5 Billion to Acquire Parexel
2021-07-04
M&A
CrownBio Acquires Dutch CRO to Expand In Vitro Services Portfolio
2021-05-07
M&A
With Hopes to Lead CRO Industry, Thermo Fisher Bids $17.4 Billion on Latest Acquisition
2021-04-15
M&A
Dublin-Based ICON to Acquire Rival CRO for a Whopping $12 Billion
2021-03-01
Remote Care Powered CURE-19 Platform Enables At Home COVID-19 Clinical Trials
2020-05-10
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top